IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
newsbyte:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Mon, 20 Oct 2008 08:56:42 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (16 lines) 
FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar 
Depression and Bipolar Mania

 From PharmaLive News Archive - Oct 10, 2008

LONDON, Oct. 10, 2008--AstraZeneca today announced that the US FDA has 
approved once-daily Seroquel XR (quetiapine fumarate) Extended-Release 
Tablets for the acute treatment of the depressive episodes associated 
with bipolar disorder, the manic and mixed episodes associated with 
bipolar I disorder, and the maintenance treatment of bipolar I disorder 
as adjunctive therapy to lithium or divalproex.



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2